Background: Glioblastomas are heterogeneous tumors composed of a necrotic and tumor core and an invasive periphery.
Methods: Here, we performed a proteomics analysis of laser-capture micro-dissected glioblastoma core and invasive areas of patient-derived xenografts.
Results: Bioinformatics analysis identified enriched proteins in central and invasive tumor areas. Novel markers of invasion were identified, the genes proteolipid protein 1 (PLP1) and Dynamin-1 (DNM1), which were subsequently validated in tumors and by functional assays.
Conclusions: In summary, our results identify new networks and molecules that may play an important role in glioblastoma development and may constitute potential novel therapeutic targets.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212852 | PMC |
http://dx.doi.org/10.1093/noajnl/vdz029 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!